[{"address1": "401 Professional Drive", "address2": "Suite 260", "city": "Gaithersburg", "state": "MD", "zip": "20879", "country": "United States", "phone": "240 403 4212", "website": "https://www.shuttlepharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mira  Jung Ph.D.", "age": 75, "title": "Co-Founder & Chief Scientific Officer for Biology", "yearBorn": 1949, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy J. Lorber CPA", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 177511, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tyvin A. Rich M.D.", "age": 76, "title": "Chief Clinical Officer & Chief Medical Officer", "yearBorn": 1948, "fiscalYear": 2024, "totalPay": 218000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael P. Vander Hoek", "age": 64, "title": "Vice President for Operations and Regulatory", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 506634, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher Robert Cooper BBA, M.B.A., MBA", "age": 54, "title": "Interim Chief Executive Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Milton  Brown CSC, M.D., Ph.D.", "age": 59, "title": "Co-Founder", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.254, "open": 4.25, "dayLow": 4.245, "dayHigh": 4.5608, "regularMarketPreviousClose": 4.254, "regularMarketOpen": 4.25, "regularMarketDayLow": 4.245, "regularMarketDayHigh": 4.5608, "payoutRatio": 0.0, "beta": 0.487, "volume": 101808, "regularMarketVolume": 101808, "averageVolume": 101996, "averageVolume10days": 141430, "averageDailyVolume10Day": 141430, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 4797063, "fiftyTwoWeekLow": 3.0, "fiftyTwoWeekHigh": 56.25, "allTimeHigh": 25252.0, "allTimeLow": 3.0, "fiftyDayAverage": 3.66492, "twoHundredDayAverage": 8.97133, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 692372, "profitMargins": 0.0, "floatShares": 987081, "sharesOutstanding": 1070773, "sharesShort": 16054, "sharesShortPriorMonth": 16865, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.015, "heldPercentInsiders": 0.049089998, "heldPercentInstitutions": 0.05672, "shortRatio": 0.56, "shortPercentOfFloat": 0.0154, "impliedSharesOutstanding": 1070773, "bookValue": 3.367, "priceToBook": 1.3305613, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -12142023, "trailingEps": -46.34, "lastSplitFactor": "1:25", "lastSplitDate": 1750032000, "enterpriseToEbitda": -0.059, "52WeekChange": -0.8441739, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 4.48, "recommendationKey": "none", "totalCash": 4817672, "totalCashPerShare": 4.499, "ebitda": -11687718, "totalDebt": 712981, "quickRatio": 2.846, "currentRatio": 3.067, "debtToEquity": 19.775, "returnOnAssets": -1.7569001, "returnOnEquity": -5.51039, "freeCashflow": -6109847, "operatingCashflow": -10570784, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SHPH", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "longName": "Shuttle Pharmaceuticals Holdings, Inc.", "epsTrailingTwelveMonths": -46.34, "fiftyDayAverageChange": 0.8150799, "fiftyDayAverageChangePercent": 0.22240046, "twoHundredDayAverageChange": -4.4913297, "twoHundredDayAverageChangePercent": -0.50063145, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": 5.312643, "regularMarketPrice": 4.48, "postMarketChangePercent": 1.33928, "postMarketPrice": 4.54, "postMarketChange": 0.0599999, "regularMarketChange": 0.22599983, "regularMarketDayRange": "4.245 - 4.5608", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 101996, "fiftyTwoWeekLowChange": 1.48, "fiftyTwoWeekLowChangePercent": 0.49333334, "fiftyTwoWeekRange": "3.0 - 56.25", "fiftyTwoWeekHighChange": -51.77, "fiftyTwoWeekHighChangePercent": -0.92035556, "fiftyTwoWeekChangePercent": -84.41739, "shortName": "Shuttle Pharmaceuticals Holding", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1661952600000, "corporateActions": [], "postMarketTime": 1759535909, "regularMarketTime": 1759521600, "exchange": "NCM", "messageBoardId": "finmb_319499082", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Shuttle Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]